The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Co-morbidity leads to altered treatment and worse survival of elderly patients with colorectal cancer
Abstract
Background: The aim of this study was to evaluate the effects of co-morbidity on the treatment and prognosis of elderly patients with colorectal cancer. Methods: The independent influence of age and co-morbidity on treatment and survival was analysed for 6931 patients with colorectal cancer aged 50 years or more diagnosed between 1995 and 2001 in the southern part of the Netherlands. Results: Co-morbidity had no influence on resection rate. The use of adjuvant chemotherapy in patients with stage III colonic cancer was influenced by co-morbidity, especially a previous malignancy (odds ratio (OR) 0·2 (95 per cent confidence interval (c.i.) 0·1 to 0·6); P = 0·002) or chronic obstructive pulmonary disease (COPD) (OR 0·3 (95 per cent c.i. 0·1 to 0·9); P = 0·043). Co-morbidity also influenced use of adjuvant radiotherapy in patients with rectal cancer, especially the presence of hypertension in combination with diabetes (OR 0·5 (95 per cent c.i. 0·2 to 0·9); P = 0·031). Co-morbidity influenced survival (hazard ratio up to 1·6), when adjusted for age, sex, tumour stage and treatment. The greatest influence on survival of patients with colonic cancer was previous malignancy, cardiovascular disease and COPD, and that of patients with rectal cancer was COPD, hypertension, and hypertension in combination with diabetes. Conclusion: Elderly patients with co-morbidity were treated less aggressively and had a worse survival than those with no concomitant disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preoperative Radiotherapy Combined with Total Mesorectal Excision for Resectable Rectal Cancer
Kapiteijn, E., Marijnen, C. A. M., Nagtegaal, I. D., Putter, H., Steup, W. H., Wiggers, T., Rutten, H. J. T., Pahlman, L., Glimelius, B., van Krieken, J. H. J. M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010580 · Cited by 4,205
Adjuvant Therapy for Patients With Colon and Rectal Cancer
(1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03450110090034 · Cited by 1,086
Ayanian, J. Z., Zaslavsky, A. M., Fuchs, C. S., Guadagnoli, E., Creech, C. M., Cress, R. D., O’Connor, L. C., West, D. W., Allen, M. E., Wolf, R. E., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.06.178 · Cited by 308
Cited by
Barone, B. B. (2008) · JAMA · doi:10.1001/jama.2008.824 · Cited by 881
“Chia et al,42 2007 (United States) C Endometrial 19911994 No telephone number, driver’s license, or Medicare card; no physician or patient permission; contact not possible 93/739 (13) Range, 40-79 0 Mean, 9.”
The impact of comorbidity on cancer and its treatment
Sarfati, D., Koczwara, B., & Jackson, C. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21342 · Cited by 680
Prognostic impact of increasing age and co-morbidity in cancer patients: A population-based approach
Janssen-Heijnen, M. L. G., Houterman, S., Lemmens, V. E. P. P., Louwman, M. W. J., Maas, H. A. A. M., & Coebergh, J. W. W. (2005) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2005.04.008 · Cited by 379
Self-citationControversies of total mesorectal excision for rectal cancer in elderly patients
Rutten, H. J., den Dulk, M., Lemmens, V. E., van de Velde, C. J., & Marijnen, C. A. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70129-3 · Cited by 276
Self-citationBrenner, H., Bouvier, A. M., Foschi, R., Hackl, M., Larsen, I. K., Lemmens, V., Mangone, L., Francisci, S., & The EUROCARE Working Group (2012) · International Journal of Cancer · doi:10.1002/ijc.26192 · Cited by 258
Self-citation
Metadata
- Authors
- Lemmens, V. E. P. P., Janssen-Heijnen, M. L. G., Verheij, C. D. G. W., Houterman, S., Repelaer van Driel, O. J., & Coebergh, J. W. W.
- Venue
- British Journal of Surgery
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-03-18
- Volume
- 92
- Issue
- 5
- Pages
- 615-623
- ISSN
- 0007-1323 (ISSN-L)
- 1365-2168
- OpenAlex
- W2019251171
- Cited by
- 228
- References
- 3
- FWCI
- 3.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.